AnalystsLeonid TimashevLeonid Timashev's Stock Forecasts
AnalystsLeonid Timashev
Sectors:
Industries:
Analyst Ranking
Bottom 16%
#3893 out of 4573 analysts
Average Return
-1.25%
Win Rate
28%7 out of 25
Risk vs Reward
Poor
Good
Leonid Timashev's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Newamsterdam Pharma Co NvNAMS | +204.32% | $7.17 | $21.82 | 2023-10-29 - 2024-05-03 | Buy |
Edgewise Therapeutics IncEWTX | +158.20% | $7.56 | $19.52 | 2023-06-27 - 2024-05-03 | Buy |
Pyxis Oncology IncPYXS | +95.54% | $2.24 | $4.38 | 2023-09-04 - 2024-05-03 | Buy |
Edgewise Therapeutics IncEWTX | +29.44% | $15.08 | $19.52 | 2024-04-21 - 2024-05-03 | Buy |
Legend Biotech CorpLEGN | +26.23% | $46.06 | $58.14 | 2023-03-23 - 2024-03-22 | Buy |
Leonid Timashev Analyst Color
Get additional color on Leonid Timashev's coverage of popular stocks
Leonid Timashev's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Edgewise Therapeutics IncEWTX | 5 | Buy | $32.00 | +63.93% | Maintains | 13 days ago |
Biohaven LtdBHVN | 3 | Buy | $61.00 | +49.91% | Reiterates | a month ago |
Axsome Therapeutics IncAXSM | 3 | Buy | $128.00 | +71.12% | Maintains | a month ago |
Pyxis Oncology IncPYXS | 2 | Buy | $7.00 | +59.82% | Reiterates | a month ago |
Design Therapeutics IncDSGN | 7 | Hold | $4.00 | +7.53% | Reiterates | a month ago |
Legend Biotech CorpLEGN | 6 | Buy | $85.00 | +87.18% | Reiterates | 2 months ago |
Newamsterdam Pharma Co NvNAMS | 2 | Buy | $31.00 | +42.07% | Maintains | 2 months ago |
Neubase Therapeutics IncNBSE | 1 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.